Semih Doğan
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
-
- Cancer Genomics and Diagnostics 7
- Breast Cancer Treatment Studies 3
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Global Cancer Incidence and Screening 1
- Co-authors
- Fabrice André (7 shared papers)Fabrice Barlési (1 shared paper)Mihaela Aldea (2 shared papers)Aurélien Marabelle (1 shared paper)Jean‐Charles Soria (1 shared paper)Qibo Zhang (2 shared papers)Timothy J. Mitchell (2 shared papers)Adam H.R. Finn (2 shared papers)
- Journals
- Annals of Oncology (4 papers)Cancer Discovery (3 papers)Current Opinion in Oncology (1 paper)European Urology Oncology (1 paper)JAMA Network Open (1 paper)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Semih Doğan
19 papers receiving 2.5k citations
Semih Doğan's Hit Papers
Peers
Comparison fields: 5 of 90
- Cancer Research 713
- Oncology 561
- Pulmonary and Respiratory Medicine 511
- Health Informatics 31
- Molecular Biology 539
Countries citing papers authored by Semih Doğan
This map shows the geographic impact of Semih Doğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Semih Doğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Semih Doğan more than expected).
Fields of papers citing papers by Semih Doğan
This network shows the impact of papers produced by Semih Doğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Semih Doğan. The network helps show where Semih Doğan may publish in the future.
Co-authors
The 25 scholars most cited alongside Semih Doğan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | AACR Project GENIE: Powering Precision Medicine through an International Consortium Hit paper breakdown → | 2017 | 1472 |
| 2 | Genomic characterization of metastatic breast cancers Hit paper breakdown → | 2019 | 532 |
| 3 | Overcoming Resistance to Tumor-Targeted and Immune-Targeted Therapies Hit paper breakdown → | 2021 | 232 |
| 4 | 2020 | 44 | |
| 5 | 2008 | 37 | |
| 6 | 2021 | 36 | |
| 7 | 2019 | 30 | |
| 8 | 2021 | 25 | |
| 9 | 2019 | 22 | |
| 10 | 2010 | 20 | |
| 11 | 2024 | 14 | |
| 12 | 2022 | 12 | |
| 13 | 2017 | 8 | |
| 14 | 2008 | 7 | |
| 15 | 2013 | 6 | |
| 16 | 2023 | 5 | |
| 17 | 2016 | 4 | |
| 18 | 2010 | 2 | |
| 19 | 2013 | 2 |
About Semih Doğan
Semih Doğan is a scholar working on Cancer Research, Oncology, Pharmacology, Pulmonary and Respiratory Medicine and Statistics and Probability, having authored 19 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (3 papers), Breast Cancer Treatment Studies (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Pharmaceutical industry and healthcare (2 papers), Statistical Methods in Clinical Trials (2 papers), Immune Response and Inflammation (2 papers) and Global Cancer Incidence and Screening (1 paper). The work is most often cited by research in Cancer Research (713 citations), Oncology (561 citations), Pulmonary and Respiratory Medicine (511 citations), Health Informatics (31 citations) and Molecular Biology (539 citations). Semih Doğan has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Fabrice André, Fabrice Barlési, Mihaela Aldea, Aurélien Marabelle, Jean‐Charles Soria, Qibo Zhang, Timothy J. Mitchell, Adam H.R. Finn, Jolanta Bernatoniene and James C. Paton. Their work appears in journals such as Annals of Oncology, Cancer Discovery, Current Opinion in Oncology, European Urology Oncology and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.